CUSIP 36269B105COMGANXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
48 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Marshall Wace, LLP | 1.66M | $5.35M | +1.49M | Added |
| 2 | Potomac Capital Management, Inc. | 1.01M | $3.25M | +1.01M | New Position |
| 3 | Jones Financial Companies Lllp | 702.2K | $2.26M | +25.4K | Added |
| 4 | Susquehanna International Group, LLP | 684.3K | $2.20M |
| +603.9K |
| Added |
| 5 | Vanguard Group Inc | 569.9K | $1.84M | +35.5K | Added |
| 6 | Dme Capital Management, LP | 566.1K | $1.82M | 0 | Held |
| 7 | Geode Capital Management, LLC | 397.9K | $1.28M | +53.8K | Added |
| 8 | Jane Street Group, LLC | 242.3K | $780.3K | +169.9K | Added |
| 9 | Blackrock, Inc. | 209.6K | $674.8K | +93.4K | Added |
| 10 | Cresset Asset Management, LLC | 160.0K | $515.2K | +160.0K | New |
See every fund holding Gain Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders